Category: sars-cov-2

FDA approves a rapid COVID-19 test that uses CRISPR

[ad_1] “Sherlock enables rapid identification of a single alteration in a DNA or RNA sequence in a single molecule,” said Sherlock Biosciences co-founder David Walt. “That precision, coupled with its capability to be deployed to multiplex over 100 targets or as a simple point-of-care system, will make it a critical addition to the arsenal of […]